D-0685-2026 Class II Ongoing
FDA drug recall D-0685-2026 was initiated by Bell Pharmaceuticals, Inc on Jun 25, 2026 and is designated Class II. Reason for recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). The recall status is ongoing. Affected quantity: 5, 471 units.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 22, 2026
- Initiation Date
- Jun 25, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5, 471 units
Product description
LEADER, Carbamide Peroxide 6.5%, 0.5 Fl Oz (15 mL), a) Kit -1 RUBBER BULB SYRINGE, 0.5 FL OZ DROPS, (NDC 70000-0689-1); b) 1 bottle (NDC 70000-0688-1), DIST. BY CARDINAL HEALTH, DUBLIN, OH 43017.
Reason for recall
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Distribution pattern
U.S Nationwide
Code information
Lot: a) 1505333, expires: 2027-04; b) 1505144, 1505302, expires: 2027-04.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0685-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026